13F HOLDINGS REPORT
Exome Asset Management LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001420506-25-000519
Total Value
$133.1M
Positions
59
Other Managers
0
Confidential Omitted
No
Holdings (59)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRIDGEBIO PHARMA INC | BBIO | 246,700 | $6.8M | 5.09% |
| 2 | ELI LILLY & CO | LLY | 8,247 | $6.4M | 4.78% |
| 3 | GERON CORP | GERN | 1,561,152 | $5.6M | 4.22% |
| 4 | HUMANA INC | HUM | 18,066 | $4.6M | 3.44% |
| 5 | GUARDANT HEALTH INC | GH | 147,800 | $4.5M | 3.39% |
| 6 | RELAY THERAPEUTICS INC | RLAY | 1,083,487 | $4.5M | 3.35% |
| 7 | DISC MEDICINE INC | IRON | 69,072 | $4.4M | 3.29% |
| 8 | SYNDAX PHARMACEUTICALS INC | SNDX | 318,900 | $4.2M | 3.17% |
| 9 | ARVINAS INC | ARVN | 218,700 | $4.2M | 3.15% |
| 10 | STRUCTURE THERAPEUTICS INC | GPCR | 151,965 | $4.1M | 3.10% |
| 11 | INTUITIVE SURGICAL INC | ISRG | 7,427 | $3.9M | 2.91% |
| 12 | APELLIS PHARMACEUTICALS INC | APLS | 119,467 | $3.8M | 2.86% |
| 13 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 65,200 | $3.7M | 2.77% |
| 14 | BOSTON SCIENTIFIC CORP | BSX | 40,500 | $3.6M | 2.72% |
| 15 | NATERA INC | NTRA | 22,450 | $3.6M | 2.67% |
| 16 | SOLENO THERAPEUTICS INC | SLNO | 77,285 | $3.5M | 2.61% |
| 17 | SCHOLAR ROCK HLDG CORP | SRRK | 77,439 | $3.3M | 2.51% |
| 18 | NUVALENT INC | NUVL | 40,580 | $3.2M | 2.39% |
| 19 | CYTOKINETICS INC | CYTK | 65,883 | $3.1M | 2.33% |
| 20 | BLUEPRINT MEDICINES CORP | 09627Y109 | 31,800 | $2.8M | 2.08% |
| 21 | GILEAD SCIENCES INC | GILD | 29,700 | $2.7M | 2.06% |
| 22 | SUMMIT THERAPEUTICS INC | SMMT | 130,412 | $2.3M | 1.75% |
| 23 | CENTESSA PHARMACEUTICALS PLC | CNTA | 137,716 | $2.3M | 1.73% |
| 24 | EDGEWISE THERAPEUTICS INC | EWTX | 81,473 | $2.2M | 1.63% |
| 25 | JANUX THERAPEUTICS INC | JANX | 40,123 | $2.1M | 1.61% |
| 26 | SAVARA INC | SVRA | 699,698 | $2.1M | 1.61% |
| 27 | IONIS PHARMACEUTICALS INC | IONS | 61,367 | $2.1M | 1.61% |
| 28 | PENUMBRA INC | PEN | 9,000 | $2.1M | 1.61% |
| 29 | ROCKET PHARMACEUTICALS INC | RCKTW | 159,552 | $2.0M | 1.51% |
| 30 | AKERO THERAPEUTICS INC | 00973Y108 | 68,608 | $1.9M | 1.43% |
| 31 | DR REDDYS LABS LTD | 256135203 | 117,500 | $1.9M | 1.39% |
| 32 | BEIGENE LTD | BEIGF | 10,000 | $1.8M | 1.39% |
| 33 | 89BIO INC | 282559103 | 225,323 | $1.8M | 1.32% |
| 34 | TARSUS PHARMACEUTICALS INC | TARS | 28,178 | $1.6M | 1.17% |
| 35 | KARYOPHARM THERAPEUTICS INC | KPTI | 2,000,000 | $1.6M | 1.17% |
| 36 | PLIANT THERAPEUTICS INC | PLRX | 103,504 | $1.4M | 1.02% |
| 37 | FULCRUM THERAPEUTICS INC | FULC | 283,599 | $1.3M | 1.00% |
| 38 | STOKE THERAPEUTICS INC | STOK | 113,096 | $1.2M | 0.94% |
| 39 | LEGEND BIOTECH CORP | LEGN | 37,600 | $1.2M | 0.92% |
| 40 | TECTONIC THERAPEUTIC INC | TECX | 26,081 | $1.2M | 0.90% |
| 41 | ALVOTECH | ALVOW | 90,100 | $1.2M | 0.90% |
| 42 | VYNE THERAPEUTICS INC | VYNE | 353,434 | $1.2M | 0.89% |
| 43 | ELEDON PHARMACEUTICALS INC | ELDN | 256,373 | $1.1M | 0.79% |
| 44 | BIOHAVEN LTD | BHVN | 28,159 | $1.1M | 0.79% |
| 45 | GOSSAMER BIO INC | GOSS | 1,097,999 | $993,250 | 0.75% |
| 46 | ACLARIS THERAPEUTICS INC | ACRS | 389,333 | $965,546 | 0.73% |
| 47 | ANNEXON INC | ANNX | 144,830 | $742,978 | 0.56% |
| 48 | VERU INC | VERU | 1,117,600 | $739,509 | 0.56% |
| 49 | ACELYRIN INC | 00445A100 | 234,435 | $736,126 | 0.55% |
| 50 | REPLIMUNE GROUP INC | REPL | 54,738 | $662,877 | 0.50% |
| 51 | ESTABLISHMENT LABS HLDGS INC | ESTA | 13,100 | $603,517 | 0.45% |
| 52 | NEKTAR THERAPEUTICS | NKTR | 618,174 | $574,902 | 0.43% |
| 53 | APREA THERAPEUTICS INC | APRE | 127,960 | $419,709 | 0.32% |
| 54 | AKEBIA THERAPEUTICS INC | AKBA | 205,956 | $391,316 | 0.29% |
| 55 | MADRIGAL PHARMACEUTICALS INC | MDGL | 987 | $304,559 | 0.23% |
| 56 | LEAP THERAPEUTICS INC | CYPH | 102,631 | $295,064 | 0.22% |
| 57 | MERSANA THERAPEUTICS INC | 59045L106 | 172,924 | $249,723 | 0.19% |
| 58 | NEUMORA THERAPEUTICS INC. | NMRA | 600 | $207,000 | 0.16% |
| 59 | ARBUTUS BIOPHARMA CORP | ABUS | 28,300 | $92,541 | 0.07% |